Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page
- CheckyesterdayChange DetectedA new revision tag v3.5.3 was added and the previous v3.5.2 tag removed, signaling an updated version of the study record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a backend/software version update and does not modify the study details or page content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated to v3.5.0; the previous Revision: v3.4.3 label was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2; no user-facing content changes detected.SummaryDifference0.1%

- Check58 days agoChange DetectedPublications section added with a cited Oncoimmunology article and a note that these items are auto-filled from PubMed. This contextual information does not alter the trial details, eligibility criteria, or study design on the page.SummaryDifference0.3%

- Check79 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.